All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

32

Reset

32 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • OrelabrutinibICP-022Phase 311 trials

    Beijing InnoCare Pharma Tech Co., Ltd. · Mantle Cell Lymphoma, Part 1:r/r B-cell Malignancies, Part 2:B-cell Malignancies

  • AZD0120GC012FPhase 39 trials

    AstraZeneca · Newly Diagnosed Multiple Myeloma (NDMM), Relapsed AL Amyloidosis, Refractory AL Amyloidosis

  • FrexalimabSAR441344Phase 39 trials

    Sanofi · Multiple Sclerosis, Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion

  • FenebrutinibRO7010939, GDC-0853Phase 36 trials

    Roche (Genentech) · Relapsing Multiple Sclerosis, Multiple Sclerosis, Multiple Sclerosis, Primary Progressive

  • PPV2323-valent Pneumococcal Polysaccharide Vaccine, lot 1Phase 36 trials

    Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · Healthy Volunteers, Streptococcus Pneumoniae Infection, Pneumococcal Disease

  • RocbrutinibLP-168, NWP-775Phase 36 trials

    Guangzhou Lupeng Pharmaceutical Company LTD. · Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL), Mantle Cell Lymphoma

  • rHuPH20Phase 35 trials

    Bristol Myers Squibb · Melanoma, Relapsing-remitting Multiple Sclerosis, Clear Cell Renal Cell Carcinoma

  • ObexelimabPhase 34 trials

    Zenas BioPharma (USA), LLC · Systemic Lupus Erythematosus, Warm Autoimmune Hemolytic Anemia, Relapsing Multiple Sclerosis

  • IMU-838Vidofludimus calciumPhase 33 trials

    Immunic AG · Relapsing-Remitting Multiple Sclerosis (RRMS), Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting

  • Sanofi · Multiple Sclerosis

  • TolebrutinibSAR442168Phase 33 trials

    Sanofi · Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis

  • KYV-101Phase 32 trials

    Kyverna Therapeutics · Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis

  • Sanofi · Multiple Sclerosis

  • ABP 692Phase 31 trial

    Amgen · Relapsing-remitting Multiple Sclerosis (RRMS)

  • BCD-281Phase 31 trial

    Biocad · Relapsing-remitting Multiple Sclerosis (RRMS)

  • rapcabtagene autoleucelYTB323Phase 28 trials

    Novartis · Lupus Nephritis, Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD), ANCA Associated Vasculitis (AAV)

  • zamtocabtagene autoleucelMB-CART2019.1Phase 25 trials

    Miltenyi Biomedicine GmbH · CAR T Cell Therapy, Mantle Cell Lymphoma (MCL), Multiple Sclerosis

  • Ever Supreme Bio Technology Co., Ltd. · COVID-19 Infection, Multiple Sclerosis, ST Elevation Myocardial Infarction

  • Zugocabtagene geleucelCTX112Phase 23 trials

    CRISPR Therapeutics AG · B-cell Lymphoma, Non-Hodgkin Lymphoma, B-cell Malignancy

  • Autologous HB-adMSCsPhase 22 trials

    Hope Biosciences LLC · Traumatic Brain Injury, Relapsing Remitting Multiple Sclerosis (RRMS), Multiple Sclerosis

  • BMS-986368CC-97489Phase 22 trials

    Bristol Myers Squibb · Agitation, Alzheimer Disease, Multiple Sclerosis Spasticity

  • C-CAR168Phase 22 trials

    AbelZeta Inc. · Lupus Nephritis (LN), Systemic Lupus Erythematosus (SLE), Autoimmune Diseases

  • CNMAu8gold nanocrystalsPhase 22 trials

    Clene Nanomedicine · Amyotrophic Lateral Sclerosis, Multiple Sclerosis

  • Foralumab NasalPhase 22 trials

    Tiziana Life Sciences LTD · ALS (Amyotrophic Lateral Sclerosis), ALS - Amyotrophic Lateral Sclerosis, ALS

  • BIIB091Phase 21 trial

    Biogen · Relapsing Forms of Multiple Sclerosis

  • ForalumabPhase 21 trial

    Tiziana Life Sciences LTD · Secondary Progressive Multiple Sclerosis

  • PIPE-307Phase 21 trial

    Johnson & Johnson (Janssen) · Relapsing Remitting Multiple Sclerosis

  • PRO-1562Phase 21 trial

    Progentos Therapeutics · Multiple Sclerosis

  • RO7268489Phase 21 trial

    Roche (Genentech) · Progressive Multiple Sclerosis

  • SUN-627NEU-627, N-004850Phase 21 trial

    Sundance Biosciences, Inc. · Primary Progressive Multiple Sclerosis, Primary Progressive MS, Primary Progressive Multiple Sclerosis (PPMS)

  • TRX319Phase 21 trial

    Tr1X, Inc. · Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis (SPMS), Multiple Sclerosis

  • VT7208Phase 21 trial

    Vidya Therapeutics Inc · Multiple Sclerosis

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.